Pure Global

FARAWAVE NAV Pulsed Field Ablation Catheter - Cardiac irreversible electroporation system catheter - ARTG 469731

Access comprehensive regulatory information for FARAWAVE NAV Pulsed Field Ablation Catheter - Cardiac irreversible electroporation system catheter in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 469731 and sponsored by Boston Scientific Pty Ltd, manufactured by Boston Scientific Corporation in United States of America. The device registration started on November 21, 2024.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
ARTG 469731
Class III
FARAWAVE NAV Pulsed Field Ablation Catheter - Cardiac irreversible electroporation system catheter
ARTG ID: 469731
Good Name: Boston Scientific Pty Ltd - FARAWAVE NAV Pulsed Field Ablation Catheter - Cardiac irreversible electroporation system catheter
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

Indicated for the isolation of pulmonary veins in the treatment of drug-refractory recurrent, symptomatic paroxysmal atrial fibrillation.

Device Classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
469731
Start Date
November 21, 2024
Effective Date
November 21, 2024
Manufacturer
Country
United States of America
Address
300 Boston Scientific Way, Marlborough, MA, 01752